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Stress initiates adaptive processes that allow the organism to physiologically cope
with prolonged or intermittent exposure to real or perceived threats. A major
component of this response is repeated activation of glucocorticoid secretion by the
hypothalamo-pituitary-adrenocortical (HPA) axis, which promotes redistribution of energy
in a wide range of organ systems, including the brain. Prolonged or cumulative increases
in glucocorticoid secretion can reduce benefits afforded by enhanced stress reactivity
and eventually become maladaptive. The long-term impact of stress is kept in check by
the process of habituation, which reduces HPA axis responses upon repeated exposure
to homotypic stressors and likely limits deleterious actions of prolonged glucocorticoid
secretion. Habituation is regulated by limbic stress-regulatory sites, and is at least
in part glucocorticoid feedback-dependent. Chronic stress also sensitizes reactivity to
new stimuli. While sensitization may be important in maintaining response flexibility in
response to new threats, it may also add to the cumulative impact of glucocorticoids
on the brain and body. Finally, unpredictable or severe stress exposure may cause
long-term and lasting dysregulation of the HPA axis, likely due to altered limbic control
of stress effector pathways. Stress-related disorders, such as depression and PTSD, are
accompanied by glucocorticoid imbalances and structural/ functional alterations in limbic
circuits that resemble those seen following chronic stress, suggesting that inappropriate
processing of stressful information may be part of the pathological process.
Keywords: glucocorticoid receptor, hypothalamo-pituitary-adrenal axis, limbic system, stress-related diseases,
stress habituation, stress sensitization
THE PROBLEM OF CHRONIC STRESS
The organismal response to stress (defined here as a real or per-
ceived threat to homeostasis or well-being) promotes survival via
adjustments to ongoing physiological processes and behavior. The
activation of multiple interacting processes, including the behav-
ioral, autonomic, endocrine, and immune systems, produces an
integrated stress response. While initially adaptive, prolonged
activation of molecular pathways engaged by these systems can
cause pronounced changes in physiology and behavior that have
long-term deleterious implications for survival and well-being.
In essence, prolonged or chronic stress changes the rules under
which the body regulates homeostasis, requiring new strategies
for successful adaptation. This concept lies at the heart of Selye’s
initial description of the “general adaptation syndrome,” where
after an initial “alarm” stress reaction, the organism is able to suc-
cessfully manage prolonged stress for substantial periods. Only
when homeostatic pressure becomes too great does the individ-
ual enter into a state of frank distress, with attendant morbidity
and mortality (Selye, 1950). Importantly, the process of adapta-
tion comes at a cost to the organism, as stress effector systems
are chronically mobilized to meet the homeostatic demands of
prolonged stress. Thus, stress alters the physiological milieu in
a long-term manner (adaptation through change, or “allosta-
sis”) (Sterling and Eyer, 1988), and the body’s response to these
changes lies at the center of both successful stress resilience as well
as its transition to pathology.
The literature is replete with examples of the impact of
stress on physiologic systems and behavior. For example, our
group finds that exposure to a prolonged, unpredictable and
non-habituating stress regimen (which we call “chronic vari-
able stress,” or CVS) causes marked increases in cumulative
glucocorticoid secretion, sensitization of hypothalamo-pituitary-
adrenocortical (HPA) responses to new stressors, decreased heart
rate variability, reduced weight gain, decreased sucrose prefer-
ence and increased immobility in the forced swim test (Herman
et al., 1995; Ulrich-Lai et al., 2006, 2007; Jankord et al., 2011;
Flak et al., 2012), suggesting functional changes across a vari-
ety of neurobehavioral systems in the brain. Whereas it can
be argued that the net result of these physical and behavioral
changes would be maladaptive, one has to interpret them with
respect to the new context of the individual. Most responses
to chronic stress are adaptive, that is, beneficial to the survival
of the animal. For example, increases in corticosteroid levels
promote mobilization of energy, important in times of need.
Corticosteroids also inhibit systems that channel resources to
functions such as growth and reproduction, not necessarily of
value in the midst of physiologic challenge. Similarly, behavioral
changes seen during chronic stress, while at first blush “patho-
logical,” can be argued to be beneficial in the context of chronic
challenge. For example, post-stress reductions in risk assess-
ment/behavioral withdrawal seen in so-called “anxiety” tests (e.g.,
elevated plus maze) (e.g., see Chiba et al., 2012) minimize risk
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during periods of energetic challenge. Minimizing risk may also
be linked to the switch to “habitual” behaviors observed in chron-
ically stress rodents (e.g., see Dias-Ferreira et al., 2009; Harris
et al., 2012). In a hostile environment, it may make sense to
exhibit behavioral withdrawal in order to reduce threat (i.e., make
oneself less available for predation). Even observed changes in
immobility in the forced swim test, commonly linked to depres-
sive phenotypes, may be interpreted as a means of conserving
resources during challenging times (see Hawkins et al., 1978).
Thus, while responses to chronic stress can clearly have negative
consequences, one has to consider the possibility that they may
solve pressing problems of the organism at the expense of future
success.
Chronic stress responses represent attempts at adaptation, but
as noted above can create constitute physiologic challenges in
and of themselves. Excess glucocorticoid secretion can impair
numerous bodily systems if extended in time; enhanced sympa-
thetic drive can lead to cardiovascular disease; and “conserva-
tive” behavioral strategies can lessen opportunities to find new
food and water sources, more secure environmental surround-
ings and mates. Thus, at some point, the initially “adaptive”
characteristics of chronic stress reactivity can cross over to the
realm of “maladaptation,” defined as biological and behavioral
responses that are counterproductive to the best interests of the
organism. The switch from “adaptive” to “maladaptive” stress
responses will be heavily dependent on the constitution of the
individual, based on genetic and acquired strategies to max-
imize efficiency and limit overdrive of stress systems. Stress
“pathologies” can arise as a result of maladaptive chronic stress
responses, either as a result of systemic diseases of stress reg-
ulatory systems or pervasive activation of stress effectors in
inappropriate contexts. It is important to note that the concept
of “maladaptation” is not synonymous with physiologic dis-
tress. Maladaptation per se need not be sufficient to cause frank
morbidity on its own, but may degrade the well-being of the
individual or make it more vulnerable to subsequent physiologic
insults.
The current review will address the problem of chronic
stress, adaptation and maladaptation from the perspective of
the HPA axis, perhaps the most thoroughly studied system
linked to stress responses. The consequences of HPA axis
activation are far-reaching, likely due to the ubiquity of gluco-
corticoid hormone receptors across multiple body compartments
and the widespread impact of glucocorticoid hormones on
gene expression. Glucocorticoid secretion is generally linked
to stressful events. Consequently, glucocorticoids are often
referred to as “stress hormones,” a designation that undermines
appreciation of their primary functions, including redistribu-
tion of energy. Indeed, so-called “stress levels” of glucocor-
ticoid secretion can even be observed at the peak of the
circadian corticosteroid rhythm, representing a flux in hor-
mone aimed at increasing energy supplies for the active, wak-
ing hours. With this caveat in mind, consistent activation of
this system constitutes both a mechanism of stress adapta-
tion and a potential challenge for the organism, the balance
of which determines resistance or susceptibility to long-term
pathologies.
STRESS ADAPTATION
To be clear, glucocorticoid responses are required for survival
and adaptation. The relationship between glucocorticoid secre-
tion and adaptation (e.g., in terms of appropriate behavioral
performance) is often described as an “inverted-U” shaped curve,
wherein an optimal level of glucocorticoid signaling is required to
produce the most effective organismal response (De Kloet et al.,
1998) (Figure 1). Thus, both hypo- and hyper-secretion generate
poor responses, whereas an intermediate level of corticosteroids
fosters superior performance. Work fromDe Kloet and colleagues
suggests that the molecular basis of this curious phenomenon
lies in the differing binding affinities and signaling character-
istics of the two primary corticosteroid receptors in brain (De
Kloet et al., 1998). The mineralocorticoid receptor (MR) binds
low levels of glucocorticoids, and fosters cellular activation (hip-
pocampus) andmaintains basal circadian corticosteroid rhythms.
The glucocorticoid receptor (GR) binds glucocorticoids across
the circadian peak/stress range, and appears to inhibit hippocam-
pal neurons and controls the magnitude of HPA axis responses
to stress via negative feedback mechanisms (Reul and Dekloet,
1985; De Kloet et al., 1998). While MR and GR share virtually
identical DNA binding domains, their transactivation domains
are distinct, meaning that they can have very different gene tar-
gets (Datson et al., 2001, 2008). Moreover, there is evidence that
the two receptors heterodimerize (Trapp et al., 1994; Nishi et al.,
2004), a process that introduces the capacity to temper specific
MR and GR genomic signals and perhaps introduce new types of
genomic interactions.
The right arm of the inverted U-shaped curve is likely due to
potential catabolic effects of glucocorticoids on physiological and
FIGURE 1 | Inverted U-shaped relationship between physiologic or
behavioral “performance’ and HPA axis output (corticosterone
secretion). Secretion of glucocorticoids following stress is likely an
adaptive function, supplying needed energy to meet real or potential
threats. Underactive stress axis activation does not mobilize the resources
needed to meet a challenge, resulting in suboptimal performance (left arm
of the U-shaped curve). Excessive glucocorticoid secretion (right arm of the
U-shaped curve) can cause excessive or prolonged catabolic responses,
which can result in turn-off of vital stress counter-regulatory systems or
energetic challenge in the CNS (see text).
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cellular functions, most likely mediated by the GR. In keeping
with their role in energy redistribution, glucocorticoids pro-
mote energymobilization, including glycogenolysis, lipolysis, and
proteolysis (Munck et al., 1984). Thus, these hormones pro-
mote processes that, while good for the organism in moderation,
can cause long-term cellular energy depletion at high levels. In
addition to effects on catabolism, glucocorticoids also inhibit pro-
cesses related to growth and reproduction (Munck et al., 1984)
(the organism does not need to be concerned about growing if
energy reserves are being depleted). In brain, high levels of gluco-
corticoids can inhibit glial glucose transport (Virgin et al., 1991)
and impair neuronal survival under conditions of energetic chal-
lenge (Tombaugh et al., 1992). Glucocorticoids can also inhibit
expression of key neurotrophic molecules, such as brain-derived
neurotrophic factor (Smith et al., 1995; Schaaf et al., 2000),
and impair hippocampal neurogenesis (Gould and Tanapat,
1999). Finally, glucocorticoids down-regulate GR expression in
limbic regions controlling negative feedback (e.g., hippocam-
pus, prefrontal c) (Mizoguchi et al., 2003; Chiba et al., 2012),
which limits the ability of the system to control glucocorticoid
homeostasis.
Activation of glucocorticoid secretion is mediated by neuronal
signals. The neuroendocrine cascade culminating in corticos-
teroid release is initiated by stimuli impinging on hypophys-
iotrophic neurons in the medial parvocellular division of the
hypothalamic paraventricular nucleus (PVN). These neurons
synthesize ACTH secretagogues [themost prominent of which are
corticotropin-releasing hormone (CRH) and arginine vasopres-
sion (AVP)] that are released into the hypophysial portal circula-
tion (median eminence) and transported to the anterior pituitary
gland. Corticotropes respond to CRH and AVP by releasing
ACTH, which is released into the systemic circulation and causes
synthesis and release of glucocorticoids at the level of the adrenal
gland. Glucocorticoid secretion is self-limited, undergoing end-
product feedback inhibition via binding GRs in multiple brain
regions as well as the pituitary gland (Keller-Wood and Dallman,
1984; Myers et al., 2012b). The net result is an HPA axis “stress
response” that has a rapid onset and more gradual wane, with
glucocorticoid secretion generally peaking in 15–30min and last-
ing up to several hours, depending on the severity of the stressor
(Figure 2). The shape of the response underscores its adaptive
value in the short-term, and limits the possible negative effects
of a prolonged glucocorticoid response.
Stimulation of the HPA axis occurs in reaction to or in antic-
ipation of stress (Herman et al., 2003; Ulrich-Lai and Herman,
2009). Physiological threats (systemic stressors) initiate largely
reflexive responses that can be triggered without conscious per-
ception. However, anticipation of threat requires the organism
to interpret the significance of multi-modal sensory information
with respect to previous experience. Thus, stimuli that pre-
dict adversity (psychogenic stressors) can generate an HPA axis
response in the absence of an existing physiologic insult. The rel-
evance of the anticipatory glucocorticoid response hinges on the
predicted need for adaptive hormonal secretion in order to redis-
tribute resources (e.g., energy) to meet the challenge (Herman
et al., 2003; Ulrich-Lai and Herman, 2009). Appropriate activa-
tion of the HPA axis by acute stress is critical, as inappropriately
FIGURE 2 | Time domains of glucocorticoid feedback. Fast
glucocorticoid feedback occurs in the realm of minutes to seconds, and
likely involves membrane effects of glucocorticoids on endocannabinoid
synthesis at the PVN. Delayed feedback controls return of glucocorticoid
levels to baseline, and likely involves glucocorticoid feedback signals at
multiple brain regions, including the prefrontal cortex, ventral subiculum
(hippocampus) and possibly the nucleus of the solitary tract. It is not clear
whether delayed feedback is genomic, non-genomic or a combination of
both.
low reactivity can hinder physiological resilience and cognitive
processes (e.g., learning and memory) (Diamond et al., 1992;
Reber et al., 2007). However, many of the effects of glucocor-
ticoids that are beneficial for short-term survival can be coun-
terproductive or even deleterious if prolonged. Therefore, the
activation and inhibition of glucocorticoid release is a tempo-
rally regulated process involving rapid neuronal activation and
efficient inhibition.
Control of glucocorticoid secretion is accomplished by mul-
tiple mechanisms. The first line of defense is rapid shut-off of
ACTH release by glucocorticoids secreted in response to stress.
Rapid inhibition is almost certainly non-genomic, and is medi-
ated in part by direct feedback onto PVN CRH neurons and at
the pituitary (John et al., 2004; Tasker and Herman, 2011). At
the PVN, so-called “fast feedback” is mediated by membrane
actions of glucocorticoids, which cause local mobilization of
endocannabinoids and subsequent inhibition of excitatory affer-
ent input (Di et al., 2003; Evanson et al., 2010). Fast feedback
inhibits ACTH release within minutes, and affects the ampli-
tude of the stress response (Keller-Wood and Dallman, 1984).
Glucocorticoids also act via the MR to rapidly enhance the
excitability of hippocampal and basolateral amygdala neurons
via a non-genomic mechanism. Both regions are upstream of
the PVN, and thus binding via the MR may impact HPA drive
via synaptic mechanisms (Pasricha et al., 2010). The eventual
shut-off of the HPA axis stress response (return to baseline) is
thought to be mediated by feedback working through limbic
circuitry (Jacobson and Sapolsky, 1991; Sapolsky et al., 1991;
Boyle et al., 2005; Furay et al., 2008). Shut-off occurs in the
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time realm of genomic actions, and may reflect cellular changes
in pathways impinging on the PVN. However, it remains pos-
sible that delayed shut-off may be mediated at least in part by
non-genomic signaling.
Intracellular GR (and MR) signaling is subject to modulation
by other proteins, which may affect function in the context of
stress. For example, the GR-binding factor FK506 binding pro-
tein 51 (also known as FKBP5) reduces glucocorticoid binding
affinity and GR nuclear translocation (Binder, 2009). In PFC,
chronic stress enhances expression of FKBP5, which is correlated
with impaired GR nuclear trafficking and reduced expression of
GR-regulated genes (Guidotti et al., 2012). Stress-related changes
in expression of FKBP5 (as well as other GR binding proteins)
may represent a mechanism for reduced feedback efficacy and
prolonged HPA axis responses (Mizoguchi et al., 2003).
Chronic stress causes a marked reorganization of the cen-
tral components of the HPA axis. Numerous studies document
increases in CRH and AVP expression in parvocellular PVN neu-
rons (Herman et al., 1995; Makino et al., 1995), consistent with
increased response capacity of the central limb of the HPA axis.
Chronic stress also causes marked structural plasticity in CRH
neurons. Glutamatergic and NE terminal appositions on CRH
somata and dendrites increase with chronic stress, consistent
with enhanced excitatory drive (Flak et al., 2009). There is also
evidence that PVN GABAergic signaling is impaired following
chronic stress. Chronic variable stress exposure causes decreases
in GABA-A receptor subunit mRNAs, which would be predicted
to diminish the potential for inhibition of the HPA axis (Cullinan,
2000). At the synaptic level, chronic stress decreases miniature
inhibitory post-synaptic potentials in PVN neurons (Verkuyl
et al., 2004), consistent with decreased inhibitory innervation. In
addition, recent studies suggest that stress causes a reversal of the
cellular chloride gradient in parvocellular PVN neurons (Hewitt
et al., 2009), essentially negating the inhibitory impact of GABA
on post-synaptic neurons. Neuroplastic responses likely reflect
increased demand upon the CRH neurons, serving to maintain
response capacity if confronted with additional stressors.
Hyperactivity of the PVN may be linked to alterations in glu-
cocorticoid feedback in brain. Numerous studies indicate that
chronic stress decreases expression of GR in the prefrontal cor-
tex (PFC) and hippocampus (Mizoguchi et al., 2003; Chiba et al.,
2012). Lesion and stimulation studies indicate that both of these
regions play a key role in inhibition of HPA axis stress responses,
working by way of excitation of inhibitory relays into the PVN
[e.g., in the bed nucleus of the stria terminalis (BST), dorsomedial
hypothalamus and peri-PVN regions, among others] (Herman
et al., 2003; Ulrich-Lai and Herman, 2009). Local administra-
tion of glucocorticoids into the PFC reduce HPA axis responses to
stress (Diorio et al., 1993), also consistent with an important role
in feedback regulation. This conclusion is further supported by
studies demonstrating that forebrain deletion of the GR (includ-
ing the PFC and hippocampus) (Boyle et al., 2005; Furay et al.,
2008) or local knock-down of GR in the PFC (McKlveen et al.,
2013) enhance HPA axis stress responses. Thus, chronic stress-
induced reductions in PFC and hippocampal GR may remove
an important brake on the HPA axis, resulting in down-stream
changes in PVN excitability.
It is important to note that glucocorticoids also affect behav-
ioral processes that modulate the impact of stress on the organ-
ism. Behavioral analyses indicate that glucocorticoids cause
changes in learning strategy, wherein mice switch from spatial
learning to stimulus-response learning in the context of acute
stress or corticosterone. The switch in learning strategy is blocked
by an MR antagonist, suggesting effects mediated by the MR
(Schwabe et al., 2010). In addition, mice overexpressingMR fail to
extinguish conditioned fear, consistent with impaired behavioral
flexibility (Harris et al., 2012). Animals with forebrain deletion of
GR or knockdown of GR in the PFC have increased immobility
in the forced swim test (Boyle et al., 2005; McKlveen et al., 2013),
supporting a role for GR in behavioral strategy selection in this
context.
In contrast to the PFC and hippocampus, amygdalar structures
appear to be positively regulated by chronic stress. Expression
of CRH in the central nucleus of the amygdala (CeA) is
increased under conditions of chronic stress or glucocorticoid
excess (Makino et al., 1994, 1999; Shepard et al., 2000, 2003).
Moreover, glucocorticoid implants in the CeA increase corticos-
terone responses to acute stress, suggesting a positive glucocor-
ticoid feedback effect mediated by this region (Shepard et al.,
2003). The CeA is linked to excitation of the HPA axis, medi-
ated by inhibition of inhibitory relay neurons innervating the
PVN (including the BST and dorsomedial hypothalamus, which
are also implicated in inhibition by the PFC and hippocampus)
(Herman et al., 2003). Thus, in addition to impairing feedback
inhibition, chronic stress may permit feed-forward activation of
the PVN by way of the amygdala.
The impact of chronic stress is also evident at the pituitary and
adrenal. Chronic stress exposure causes up-regulation of proop-
iomelanocortin mRNA expression and protein content (Shiomi
et al., 1986), consistent with enhanced capacity for release of
ACTH. At the adrenal, chronic variable stress causes cellular
hypertrophy and hyperplasia in the zona fasciculata of the adrenal
cortex, which causes elevated responsiveness to ACTH (Ulrich-
Lai et al., 2006). The PVN, pituitary and adrenal changes occur
with the context of relatively small changes in resting glucocorti-
coid secretion, consistent with modulation of the overall capacity
of the HPA axis to respond (rather than a pronounced and pro-
longed basal hypersecretion). The peripheral changes likely reflect
the overall cumulative impact (severity) of the stress regimen, as
mild or habituating regimens may not be sufficient to cause frank
changes at the brain, pituitary, and adrenal level [e.g., attenu-
ated stress-induced adrenal hypertrophy (Flak et al., 2012) and
deceased induction of PVN vasopressin mRNA expression (Gray
et al., 2010)].
Neurocircuit mechanisms underlying generation of chronic
stress-induced HPA hyperdrive remain to be determined. In gen-
eral, lesions of brain regions known to be involved in inhibition or
excitation of acute stress reactivity do not affect the development
of HPA-relevant chronic stress symptoms. For example, lesions of
the ventral subiculum exacerbate responses to acute stress, but do
not affect basal glucocorticoid secretion, adrenal hypertrophy or
thymic atrophy following chronic stress (Herman and Mueller,
2006). Moreover, lesions of the medial and central amygdala,
putative stress excitatory regions, do not attenuate chronic stress
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responses (Prewitt and Herman, 1997; Solomon et al., 2010).
Thus, it is not clear that regions mediating acute stress responses
are required for development of chronic stress-related HPA axis
dysfunction.
HABITUATION TO REPEATED STRESS EXPOSURE
Successful adaptation to chronic stress is a dynamic process that is
dependent on the attributes of the stress exposure, such as sever-
ity, modality and duration. Stress “habituation” is thought to be
an important adaptive response to repeated challenge, wherein
responses to a given stressor decrease upon repeated exposure
and thus reduce the overall physiological burden (e.g., cumula-
tive effects of glucocorticoid secretion) with time. Animals can
generally habituate to repeated stressors (Grissom and Bhatnagar,
2009). This is evident by a marked reduction in HPA axis acti-
vation with repeated exposure to the same stimulus (Figure 3).
Habituation is observed after exposure to a wide array of stim-
uli, ranging from mild (e.g., novel environment) to severe (limb
and head immobilization) (Campmany et al., 1996; Grissom and
Bhatnagar, 2009). The rate of habituation is dependent on the
severity of the stressor (Garcia et al., 2000). Habituation is likely
mediated by diminution of central responses to the stressor; for
FIGURE 3 | Stress habituation and facilitation. Repeated exposure to the
same stressor results in progressive diminution of response magnitude,
thought to be mediated by structures such as the prefrontal cortex (PFC)
and paraventricular thalamus (PVT). Exposure to a new stressor after either
homotypic or hetertypic stressors causes a larger than normal (“sensitized’
or “facilitated’ response), which may be mediated by enhanced drive from
the basolateral amygdala (BLA), PVT or locus coeruleus (LC).
example, activation of c-fos expression in the medial parvocel-
lular PVN is markedly reduced in the PVN following repeated
restraint stress (Girotti et al., 2006). Habituation limits the over-
all physiological impact of stress, in terms of effects of repeated
stress on energy balance (i.e., minimal weight loss), adrenal
function (i.e., no adrenal hypertrophy) and cumulative corti-
costerone exposure (small decrements in thymus weight, asso-
ciated with small episodic increases in corticosterone exposure)
(Flak et al., 2012).
Changes in cumulative glucocorticoid exposure may be in
itself a factor in the habituation process. The addition of a stress
response atop the normal circadian rhythm adds to the “total”
level of glucocorticoids seen by the organism, which may mod-
ulate ongoing excitability of key regulatory sites and thereby
limit responsiveness. Habituation to repeated stress is blocked
by pre-stress injections of an MR antagonist (Cole et al., 2000),
suggesting that the process may be regulated in part by gluco-
corticoid signaling via the MR. Unlike variable or “severe” stress
regimens [e.g., chronic social stress, chronic unpredictable stress
(Chao et al., 1993; Herman et al., 1995)] repeated restraint stress
does not down-regulate GR and MR mRNA expression (hip-
pocampus) (Girotti et al., 2006), suggesting that neural feedback
mechanisms remain intact. While an elevated feedback signalmay
be relevant to habituation, it does not constrain the HPA response
to new stressors, which can be as great or greater than responses
seen in stress-naïve animals (see below) (Akana et al., 1992; Marti
et al., 1994).
The CNS mechanisms regulating stress habituation appear to
involve limbic forebrain circuitry. Functional studies indicate that
local inactivation of the ventral PFC region prior to restraint
stress blocks the development of habituation to subsequent expo-
sure, suggesting activation is necessary for the process (Weinberg
et al., 2010). The basolateral amygdala also appears essential for
HPA axis habituation, as local blockade of beta-adrenergic recep-
tors after daily stress exposure attenuates reductions in ACTH
and corticosterone release observed following repeated restraint
(Grissom and Bhatnagar, 2011). It is important to note that the
ventral prefrontal cortex has rich connections with basolateral
amygdala (McDonald et al., 1999; Vertes, 2004), and thus it is
possible that the two work in concert to promote habituation.
Other limbic forebrain regions may also play a role in the habit-
uation process; for example, diminished HPA axis responses to
repeated noise exposure is associated with a significant increase
in c-fos mRNA activation in the orbitofrontal cortex, in contrast
to decreases seen in other regions of the frontal cortex (includ-
ing the PFC) (Campeau et al., 2002). Like other limbic cortices,
the orbitofrontal cortex has potential polysynaptic connections
with subcortical limbic stress effector pathways (Price, 2007),
and increased engagement may play a role in dampening stress
responses.
There is also evidence for control of habituation at the level of
the limbic thalamus. Work from Bhatnagar and colleagues impli-
cate the paraventricular thalamus (PVT) in habituation of the
HPA axis stress response. The PVT is a midline thalamic nucleus
that interconnects with several limbic stress-regulatory regions,
including the medial PFC, basolateral amygdala and bed nucleus
of the stria terminalis. Lesions of the PVT block habituation
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of HPA axis responses to repeated restraint (Bhatnagar et al.,
2002). Moreover, PVT lesions reduced the efficacy of dexametha-
sone feedback actions on stress-induced HPA activation following
repeated but not acute restraint exposure (Jaferi et al., 2003),
suggesting that effects on habituation may be linked to gluco-
corticoid signaling. In support of this hypothesis, local block-
ade of GR and MR in the PVT prevent habituation without
affecting responses to acute stress (Jaferi and Bhatnagar, 2006),
consistent with glucocorticoid feedback effects mediated by this
region.
The habituation process may involve generalized reductions in
activation of sensory signaling pathways. For example, repeated
exposure causes marked reduction in restraint induced c-fos
mRNA activation of primary sensory cortices and thalamic sen-
sory relays (in addition to the PVNand limbic stress circuits), sug-
gesting that habituationmay be in part due to reduced strength or
salience of perceived sensory cues (Girotti et al., 2006).
It is also possible that stress habituation is mediated by struc-
tural alterations along stress integrative circuits. For example,
repeated brief restraint, a treatment that generally causes habit-
uation, causes retraction of basal dendrites of prefrontal cortical
neurons (Brown et al., 2005), which may impact down-stream
regulation of HPA axis responses. More prolonged restraint-
exposure paradigms (6 h/day, 21 days) produces dendritic retrac-
tion and spine loss in the PFC (Vyas et al., 2002; Cook and
Wellman, 2004; Radley et al., 2006, 2008) as well as retrac-
tion in subfield CA3 of the hippocampus (Magarinos and
McEwen, 1995), while causing increased dendritic complexity in
the basolateral amygdala (Vyas et al., 2002). Chronic restraint
also increases branching of GABAergic interneurons in the PFC
(Gilabert-Juan et al., 2012), suggestive of enhanced inhibition.
Structural alterationsmay affect the excitability of neurons, which
can then alter the overall balance of limbic inputs to neurons
controlling stress responsiveness.
It is important to note that habituation is not limited to
repeated stressors. Chronic unpredictable or variable stress reg-
imens also decrease physiological responses over time, although
not to the same extent as homotypic regimens. For example,
numerous studies indicate that the impact of chronic variable
stress on body weight is most profound during the initial 1–3
days of exposure, with values plateauing thereafter (Tamashiro
et al., 2007). In addition, our group has shown that chronic
variable stress (CVS)-induced corticosterone hypersecretion is
significantly reduced from the first to the second week of exposure
(unpublished observations). Adrenal hypertrophy and thymic
atrophy plateau between 1 and 2 weeks of CVS, suggesting that
the impact of chronic unpredictable stress (Paskitti et al., 2000),
at least in terms of the HPA axis, is not progressive.
CHRONIC STRESS SENSITIZATION
It should be emphasized that the “stress habituated” state does
not reflect return to normal physiologic status. Habituating reg-
imens (e.g., repeated brief restraint) result in long-term changes
in CNS stress circuits, including up-regulation of CRH expres-
sion in the PVN, even in the context of reduced corticosterone
responses to individual restraint sessions. As noted above, despite
habituation to homotypic stressors, novel stressors will induce
a disproportionately large HPA axis stress response relative to
acutely stressed controls (Figure 3) (Akana et al., 1992; Marti
et al., 1994). Increases in CRH gene expression and enhancedHPA
axis responding indicate that the underlying sensitivity of the
HPA axis is increased, even though the response to the repetitive
stimulus is diminished.
The PVT may mediate sensitization (facilitation) of responses
to novel stressors in animals habituated to a homotypic stressor.
The PVT is one of a handful of brain regions showing enhanced
Fos induction following repeated stressor exposure (e.g., cold)
(Bhatnagar and Dallman, 1998). As was the case with habitua-
tion, sensitization is blocked by lesions of the PVT, suggesting an
important role for this region in registering stressor chronicity
(Bhatnagar and Dallman, 1998). Control of HPA axis sensitiza-
tion by the PVT appears to be mediated by neuropeptidergic
circuits. Cholecystokinin (CCK) appears to be released in the
PVT during the process of sensitization and is important in lim-
iting the magnitude of sensitization (Bhatnagar et al., 2000).
Conversely, PVT activation via the orexin pathway is required for
full elaboration of stress sensitization (Heydendael et al., 2011).
Sensitization also involves noradrenergic neurons of the locus
coeruleus (LC) and/or nucleus of the solitary tract (NTS). In
cortex, repeated stress exposure sensitizes norepinephrine (NE)
release following novel stressors (Nisenbaum and Abercrombie,
1993). Moreover, increased PVN responsiveness to NE is observed
following chronic cold exposure, and appears to be required for
HPA axis sensitization (Pardon et al., 2003; Ma and Morilak,
2005). Repeated homotypic stress also increases expression of
tyrosine hydroxylase expression (rate limiting enzyme in NE syn-
thesis) in the LC (Angulo et al., 1991; Mamalaki et al., 1992; Melia
et al., 1992), suggesting that increased biosynthetic capacity in
limbic forebrain-projecting norepinephrine neurons may play a
role in the sensitization process.
Sensitization is also characteristic of models that minimize
habituation, such as CVS. ACTH and corticosterone responses to
novel stressors are augmented in CVS animals (e.g., see Ulrich-
Lai et al., 2007). As noted, habituating and non-habituation stress
regimens differ with respect to baseline endpoints (body weight,
resting corticosterone, adrenal weight and/or thymus weight), but
data comparing effects on the magnitude of sensitization are lack-
ing. Thus, it is not known whether or not unpredictable regimens
elicit more profound sensitization of the HPA axis.
Unpredictable stress regimens may also be relevant for under-
standing the lasting impact on the individual. To address this
issue, we tested the long-term impact of a CVS regimen on neu-
roendocrine as well as behavioral outcomes. Our data indicate
that CVS induces a late-emerging and long-lasting HPA axis
hyporesponsivity to novel stressors (Ostrander et al., 2006), as
well as impaired extinction of fear conditioning and enhanced
freezing responses to reminder cues (McGuire et al., 2010). These
findings indicate that chronic unpredictable stress exposure may
impair resilience to future stressful experiences.
SUCCESSFUL ADAPTATION vs. “PATHOLOGY”
Both habituating and non-habituating stress regimens present a
challenge to the organism, and both cause sensitization of stress
responses. A critical difference between the two is the cumulative
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impact on the body and brain. In habituating stress regimens, the
ability to reduce stress axis activation over time suggests that the
glucocorticoid burden may not be sufficient to cause maladapta-
tive physiological or behavioral consequences, or that it will either
take longer for cumulative damage to occur.
Maintained or enhanced stress responses to non-habituating
regimens are likely linked to both severity and predictability. As
noted above, stress regimens that vary in intensity habituate at
different rates (Garcia et al., 2000). One could posit that a stress
regimen of sufficient intensity may be able to completely block
the habituation process and lead to maladaptive consequences. In
addition, regimens that vary stressors or have uncertain outcomes
(e.g., social stressors) may not sufficiently engage habituation
mechanisms, thus allowing physiological or behavioral responses
to persist for extended periods of time. It is likely that both fac-
tors are involved in determining the net impact of chronic stress
exposure on the individual.
Mechanisms underlying the transition from adaptation to
pathology are poorly understood. Part of the problem in defin-
ing this progression lies in determining when responses meant
to be adaptive “cross over” into the realm of maladaptation. For
example, at what point does elevated glucocorticoid secretion
start to take a toll on the brain and body? The answer likely lies
at the level of the individual, and is dependent on numerous
processes including hormone clearance, MR and GR expression
levels, interactions of bound receptors with nuclear co-activators
and co-repressors, genetic predispositions and epigenetic mod-
ifications of receptor targets. From a neural perspective, the
progression from “adaptive” to “maladaptive” is likely dependent
on the degree to which the brain engages physiological responses
in an appropriate context. It is appropriate to mount a gluco-
corticoid response in response to an imminent threat; however,
engaging the HPA axis chronically or in response to innocuous
cues is not.
Importantly, context plays a role in dictating how tissues
respond to glucocorticoids. Equivalent levels of glucocorticoids
can exert different effects on cellular function depending on stress
history. For example, in hippocampus, the same dose of corticos-
terone down-regulates mTOR expression in chronically stressed
animals, but not controls (Polman et al., 2012). mTOR is an
important cell signaling pathway that is involved in neuroplas-
ticity and subsequent control of mood (Li et al., 2010). Thus, the
function of the mTOR pathway will be markedly different in the
context of stress, which subsequently affects behavioral and phys-
iological responses. These data suggest that glucocorticoids may
have exaggerated impact when an organism is exposed to stress,
even if absolute levels of hormone are not elevated to so-called
“pathophysiologic” levels.
Animal studies tracking the adaptation/pathology transition
are difficult to design, due to the lack of accompanying self-
reports signifying emotional or physical discomfort characteristic
of human stress-related disorders. We have attempted to address
this issue by comparing neural activity in habituating (repeated
restraint) vs. non-habituating (CVS) models, as the latter exhibits
a more severe HPA axis “phenotype,” in terms of baseline corti-
costerone secretion, adrenal hypertrophy and thymic involution
(Flak et al., 2012). The CVS regimen also induces behavioral
changes suggestive of altered cognition (increased immobility
in the forced swim test) and hedonic processing (decreased
sucrose preference) (Ulrich-Lai et al., 2007; Jankord et al., 2011).
Using FosB staining as a marker of long-term activation, we
demonstrated that both repeated restraint and CVS procedures
increase the number of activated neurons in key stress regula-
tory areas, including the ventral medial prefrontal cortex and
the dorsomedial hypothalamus, the latter a structure linked
to integration of endocrine, autonomic and behavioral stress
responses. However, exposure to CVS caused FosB activation in
regions not affected by repeated restraint, including the poste-
rior hypothalamus and the NTS, both of which project to the
PVN.Moreover, CVS-induced FosB expression in the medial PFC
was increased significantly beyond that seen following homo-
typic stress exposure. In contrast, unpredictable stress did not
result in decreased activation of any structures showing FosB
induction by repeated restraint, suggesting that regions are not
“de-recruited” (Flak et al., 2012). Thus, it is evident that unpre-
dictable stress recruits regions not engaged by the habituating
regimen, consistent with usage of distinct circuits under the two
conditions.
The regions “recruited” by chronic unpredictable stress are of
substantial importance in integration of stress responses across
multiple modalities. The posterior hypothalamus is involved in
coordinating defensive behaviors and autonomic responses to
stressors (Shekhar and Dimicco, 1987; Lisa et al., 1989). The
PH also sends excitatory projections to the parvocellular PVN
(Ulrich-Lai et al., 2011), and recent data from our group sug-
gests that activation of the PH potentiates HPA axis responses
to stress (Myers et al., 2012a). The NTS is traditionally thought
of as an autonomic regulatory region, but also participates
in HPA axis activation by both catecholaminergic and non-
catecholaminergic neurons (Ulrich-Lai and Herman, 2009), and
appears to play a role in regulation of anxiety-related behaviors
(via GLP-1) (Kinzig et al., 2003). Both regions receive affer-
ents from the ventral PFC (Vertes, 2004), and may together may
comprise a neural circuit responsible for perpetuation of stress
responses in the face of prolonged severe or unpredictable stress
(Figure 4).
The enhanced HPA axis drive seen in chronic unpredictable
models is likely driven by uncontrollability and uncertainty
regarding outcomes. Maier’s work elegantly demonstrates that
controllability over a stressor (shock) can protect against the
development of helplessness behavior, social inhibition and
behavioral withdrawal seen following inescapable stress (Maier
and Watkins, 2010). Importantly, brain regions controlling
development of helplessness overlap with those recruited dur-
ing exposure to unpredictable stress (i.e., ventral divisions of
the medial PFC) (Maier and Watkins, 2010). Thus, continued
drive of the HPA axis may be mediated by engagement of the
same (or parallel) circuits that control behavioral responses to
unpredictability.
Numerous psychiatric disorders are associated with dysregula-
tion of stress responses. A substantial subpopulation of depressed
individuals exhibit glucocorticoid dyshomeostasis, manifest pri-
marily as disrupted cortisol rhythms and resistance to negative
feedback (Sachar et al., 1973; Carroll, 1982; Wong et al., 2000).
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FIGURE 4 | Chronic unpredictable stress-recruited circuitry. Exposure to
chronic variable stress (CVS) selectively recruits chronic cellular activation
(in terms of FosB expression) in a discrete set of interconnected brain
regions, including the prefrontal cortex (PFC), nucleus of the solitary tract
(NTS), and the posterior hypothalamic nucleus (PH). The PH projects to both
the PH and NTS, and both PH and NTS project to the PVN, creating the
opportunity for PFC-PVN regulation in parallel, in series, or both. Via this
pathway, chronic stress can increase drive to the PFC and subsequently
cause glucocorticoid-mediated endocrine, behavioral, and metabolic
dysfunction. This figure is reprinted from Flak et al. (2012), with permission.
In fact, depression is associated with long-term HPA axis activa-
tion, manifest as adrenal hypertrophy (Amsterdam et al., 1987,
1989) as well as somatic changes indicative of increased gluco-
corticoid burden [e.g., accelerated bone loss (Gold and Chrousos,
2002)]. It is postulated that depression-related hypercortisolemia
causes glucocorticoid “resistance” by down-regulating GRs,
thereby “freeing” the HPA axis from feedback control of down-
stream stress effectors (Pariante, 2004). Accordingly, depression
may be an example of “out of context” corticosteroid secretion,
wherein hormone release is not aligned with a true threat and is
increased out of proportion with the actual objective impact of
the stressor (relative to non-depressed individuals). Thus, to some
extent, depression shares attributes with what may be considered
a disorder of chronic stress regulation.
Conversely, PTSD is linked to low cortisol levels, which appears
to be a heritable trait (Yehuda, 2009; Radley et al., 2011). In
this case, enhanced glucocorticoid feedback may impair corti-
sol responses that are essential for normal processing of stressful
information: in effect, patients are on the “left arm” of the
inverted U-shaped curve relating hormone action and perfor-
mance. A role for low “trait” cortisol in PTSD is supported by
recent studies showing efficacy of exogenous corticosteroids in
reducing symptoms in the clinic (Suris et al., 2010).
Chronic stress also causes pathological problems that extend
beyond the realm of affective disorders. For example, there is a
wealth of data linking chronic stress to age-related neurodegen-
eration and cognitive decline, likely mediated by glucocorticoid
hypersecretion (see Lupien et al., 1999; Landfield et al., 2007).
Chronic stress is also linked to somatic pathologies, including
cardiovascular disease (see Steptoe and Kivimaki, 2012) and the
metabolic syndrome (see Tamashiro et al., 2011), among oth-
ers. Indeed, accumulating evidence suggests that stress has broad
impact on virtually all physiological systems, with glucocorticoids
serving as a contextual signal that is superimposed atop specific
cellular processes.
Perhaps the key to understanding stress pathology lies in
consideration of context. In depression, for example, physio-
logical and behavioral symptoms, e.g., helplessness, anhedonia,
HPA axis dysfunction and cardiovascular pathology, all mimic
those induced by chronic stress regimens in animal models. The
key difference between the two is the context in which these
responses occur: as argued above, these behaviors and physi-
cal reactions may be entirely appropriate when an animal (or
person) is confronted with environmental or physical adversity.
In human depressives, the link with “actual” stress is less evi-
dent, raising the possibility that processes underlying the disorder
essentially permit stress related behaviors and physical reac-
tions to occur in the absence of threat. In depressed patients,
the prefrontal cortex and amygdala, two critical components
of stress circuitry, show abnormal activation patterns without
any clear threat present (Drevets, 2000; Mayberg et al., 2005),
suggesting the potential for engagement of responses out of con-
text. Mounting situationally inappropriate stress responses may
in turn contribute to cumulative damage associated with mal-
adaptive aspects of stress responses (e.g., excess glucocorticoid
action).
PERSPECTIVE
Considerable progress has been made in understanding neural
circuits and processes responsible for chronic stress habituation,
sensitization and pathology. However, the neural trigger that dif-
ferentiates successful from unsuccessful coping remains elusive.
Uncovering processes underlying the transition from adaptation
and pathology bears consideration of what constitutes “adap-
tation” and “pathology,” as many responses and behaviors that
may appear “maladaptive” make perfect sense in the appro-
priate context. Indeed, context-inappropriate physiological and
emotional responses are hallmarks of stress-related disorders
(depression, PTSD). Moving forward, animal models will need to
incorporate an appreciation of the relevance of physiologic and
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behavioral endpoints to the normal repertoire of the organism
under conditions of challenge, and develop testing conditions
that can more clearly query how chronic stress can gener-
ate situationally inappropriate responses reminiscent of human
pathology.
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